Works by Shi, Rong


Results: 708
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.

    Published in:
    Thyroid, 2019, v. 29, n. 9, p. 1269, doi. 10.1089/thy.2019.0079
    By:
    • Shi, Xiao;
    • Yu, Peng-Cheng;
    • Lei, Bo-Wen;
    • Li, Cui-Wei;
    • Zhang, Yan;
    • Tan, Li-Cheng;
    • Shi, Rong-Liang;
    • Wang, Jie;
    • Ma, Ben;
    • Xu, Wei-Bo;
    • Wang, Xiao;
    • Hu, Jia-Qian;
    • Huang, Nai-Si;
    • Wei, Wen-Jun;
    • Wang, Yu;
    • Chen, Tong-Zhen;
    • Wang, Yu-Long;
    • Ji, Qing-Hai
    Publication type:
    Article
    42
    43
    44

    Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
    By:
    • Satake, Hironaga;
    • Lee, Keun-Wook;
    • Chung, Hyun Cheol;
    • Lee, Jeeyun;
    • Yamaguchi, Kensei;
    • Chen, Jen-Shi;
    • Yoshikawa, Takaki;
    • Amagai, Kenji;
    • Yeh, Kun-Huei;
    • Goto, Masahiro;
    • Chao, Yee;
    • Lam, Ka-On;
    • Han, Shi Rong;
    • Shiratori, Shinichi;
    • Shah, Sukrut;
    • Shitara, Kohei
    Publication type:
    Article
    45
    46
    47
    48
    49
    50